Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

iNova Pharmaceuticals Pty. Ltd.

www.inovapharma.com

Latest From iNova Pharmaceuticals Pty. Ltd.

Asia Executives On The Move: Returners And Leavers At Merck; Changes At Takeda, Ono, Simcere And More

Merck China former R&D head returns after a short stint with startup Ascletis, and Takeda has a new center director for commercial health. Top executives change also take place at Ono in Korea and Simcere Pharma.

Asia Pacific Appointments

Valeant Claims Progress, Asks Investors For Patience

The Canadian specialty pharma has exceeded its near-term debt-reduction goals, but are its plans for a return to growth grounded in reality? Market analysts recommend caution, but see some reason for optimism.
Sales & Earnings Business Strategies

Valeant Returns $1bn Female Libido Drug For Free

At first glance, giving back Addyi to the original owners for next to nothing looks like a complete disaster but investors are relieved debt-ridden Valeant has managed to offload another asset.

Deals Business Strategies

Valeant Sees Sunshine On Cloudy Day, But Dermatology Recovery Just Starting

The Bausch & Lomb and Salix units are gaining sales momentum, execs said, while debt-reduction efforts remain ahead of schedule. They offered no excuses for a declining dermatology franchise, however.

Sales & Earnings Business Strategies
See All

Company Information

  • Industry
  • Pharmaceuticals
    • OTC, Consumer
  • Therapeutic Areas
  • Dermatology
  • Gastrointestinal
  • Gynecological, Urological
  • Immune Disorders
  • Infectious & Viral Diseases
  • Musculoskeletal & Connective Tissue Disorders
  • Ophthalmic
  • Respiratory, Pulmonary
  • Alias(es)
  • 3M Pharmaceuticals Pty. Ltd.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Australia
  • Parent & Subsidiaries
  • iNova Pharmaceuticals Pty. Ltd.
  • Senior Management
  • Andrew Howden, CEO
    Norbert Walther, CFO
    Cathy Withers, Dir., Mktg. & Alliance Mgt.
  • Contact Info
  • iNova Pharmaceuticals Pty. Ltd.
    Phone: (61) 2 9875 6322
    Level 10, 12 Help St.
    Chatswood, NSW 2067
    Australia
UsernamePublicRestriction

Register